USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: AFFINERGY ,INC
City: RESEARCH TRIANGLE PARK
State: NC
Zip+4: -
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $7,050,161.00 25
SBIR Phase II $25,324,803.00 14

Award List:

Discovery of Peptide-based Bone Morphogenic Protein Mimetics

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: HHS
Principal Investigator: Paul T. Hamilton
Award Amount: $256,295.00
Abstract:
DESCRIPTION (provided by applicant): In this proposal, we present a novel approach for the identification and immobilization of a BMP mimetic. We plan to use phage display technology to identify peptides that mimic BMP-like signaling of the BMP receptors. These peptides will be linked to a… More

Improved Orthopedic Implant Surface Coatings

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: HHS
Principal Investigator: Paul T. Hamilton
Award Amount: $214,330.00
Abstract:
Endosseous metallic implants are common alloplastic devices used in medicine and dentistry. The orthopedic and dental marketplace continues to grow and indications for implants are expanding. There is a perceived need to improve both the successful healing (osseointegration) and the long term… More

Discovery of a Platelet Derived Growth Factor Peptide-based Mimetic

Award Year / Program / Phase: 2006 / SBIR / Phase I
Agency: HHS
Principal Investigator: Paul T. Hamilton
Award Amount: $235,396.00
Abstract:
DESCRIPTION (provided by applicant): Summary/Abstract Diabetic foot ulcers are a significant health problem that imposes high costs on both patients and society (Boulton, Vileikyte et al. 2005). A large proportion of foot ulcers remain unresponsive to available conventional treatment and their… More

Click Chemistry for Immobilized Bone Morphogenetic Protein

Award Year / Program / Phase: 2006 / SBIR / Phase I
Agency: HHS
Principal Investigator: Shrikumar A. Nair
Award Amount: $240,279.00
Abstract:
DESCRIPTION (provided by applicant): There are over 6.3 million fractures each year in the United States of which approximately 700,000 are difficult to heal. The available treatment options for fractures that do not heal or are slow to heal are limited. Bone morphogenetic proteins are growth… More

Improved Orthopedic Implant Surface Coatings

Award Year / Program / Phase: 2006 / SBIR / Phase II
Agency: HHS
Principal Investigator: Paul T. Hamilton
Award Amount: $1,895,475.00
Abstract:
DESCRIPTION (provided by applicant): Many contemporary medical and dental therapies include the replacement or repair of tissues using materials such as metal. Currently there are at least 150,000 hip replacements, 300,000 knee replacements, and 500,000 dental implant procedures performed in the… More

Injectable BMP-2 Formulation for Fracture Healing

Award Year / Program / Phase: 2006 / SBIR / Phase I
Agency: HHS
Principal Investigator: Paul T. Hamilton
Award Amount: $204,691.00
Abstract:
DESCRIPTION (provided by applicant): Two recombinant human Bone Morphogenetic Proteins (BMP's), rhBMP-2 and rhBMP-7, are currently used in clinical applications to promote spinal fusion and fracture healing (Mont, Ragland et al. 2004). Over 6.3 million fractures occur each year in the United States… More

Growth Factor Coated Sutures for Improved Tendons Repair

Award Year / Program / Phase: 2006 / SBIR / Phase I
Agency: HHS
Principal Investigator: Paul T. Hamilton
Award Amount: $202,997.00
Abstract:
DESCRIPTION (provided by applicant): Tendon injuries are quite common and the frequency of these injuries is expected to rise as the population ages, yet continues to remain active. Long periods of immobilization and rehabilitation are required because tendon healing is a relatively slow process.… More

Interfacial Adapters for Improved Cell Delivery to Tissues

Award Year / Program / Phase: 2007 / SBIR / Phase I
Agency: HHS
Principal Investigator: Paul T. Hamilton
Award Amount: $499,880.00
Abstract:
DESCRIPTION (provided by applicant): Many human diseases can theoretically be treated by injection of healthy or engineered cells into damaged tissue, where ideally they will engraft and remodel the damaged tissue into healthy tissue. However, numerous obs tacles stand in the way of this… More

Point of Care Attachment of Multiple Antibiotics onto Metal Implants

Award Year / Program / Phase: 2007 / SBIR / Phase I
Agency: HHS
Principal Investigator: Paul T. Hamilton
Award Amount: $264,107.00
Abstract:
DESCRIPTION (provided by applicant): Infection surrounding metal implants is a common and sometimes devastating cause of implant failure in a number of fields including oral, craniomaxillofacial (CMF), orthopedic, and cardiovascular surgery. These infectio ns, which arise from the establishment of… More

Bioactive Peptide Coatings for Synthetic Bone Grafts in Dental Applications

Award Year / Program / Phase: 2007 / SBIR / Phase I
Agency: HHS
Principal Investigator: Hanne Gron
Award Amount: $264,486.00
Abstract:
DESCRIPTION (provided by applicant): According to the National Institute of Dental and Craniofacial Research, 86% of adults over 70 years have at least moderate periodontitis and over a quarter have lost their teeth, which has serious repercussion on healt h and quality of life. Because of bone loss… More

Point of Care Adult Stem Cell Isolation

Award Year / Program / Phase: 2007 / SBIR / Phase I
Agency: HHS
Principal Investigator: Benjamin M. Buehrer
Award Amount: $280,027.00
Abstract:
DESCRIPTION (provided by applicant): Approximately 500,000 bone-grafting procedures are performed each year in the United States (Boden, 2002). Autologous iliac crest bone graft continues to be the gold standard because it provides the three essential elem ents for bone formation: osteoprogenitor… More

Localized Growth Factor Therapy for Surgical Hernia Repair

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator: Paul T. Hamilton
Award Amount: $287,470.00
Abstract:
DESCRIPTION (provided by applicant): Over 700,000 surgical hernia repairs are performed each year in the United States and despite recent advances, a significant rate of recurrence persists. The incorporation of biocompatable mesh to strengthen the abdomi nal fascia has largely replaced… More

Antibiotic-binding Peptides for Biofilm Prevention on Ventriculoperitoneal Shunts

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator: Paul T. Hamilton
Award Amount: $273,644.00
Abstract:
DESCRIPTION (provided by applicant): Ventriculoperitoneal (VP) shunts are used to treat pediatric and neonatal hydrocephalus in severe cases, representing approximately 1/3rd of affected infants. Due to the high susceptibility for infection and mechanica l breakdown, the failure rate of VP shunts… More

Tissue-targeted Antibiotics for the Prevention of Surgical Site Infection

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator: Hanne Gron
Award Amount: $283,296.00
Abstract:
DESCRIPTION (provided by applicant): The Centers for Disease Control estimates that as many as 2 million people contract infections in hospitals each year, with as many as 100,000 deaths. Approximately 1/4 of hospital related infections (~500,000) are surg ical site infections. For each single… More

Self Assembling High Affinity Peptides for Point of Care Drug-Device Combinations

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $299,957.00
Abstract:
DESCRIPTION (provided by applicant): Infection surrounding metal implants is a common and sometimes devastating cause of implant failure in a number of fields including oral, craniomaxillofacial (CMF), orthopedic, and cardiovascular surgery. These infectio ns, which arise from the establishment of… More

Prohealing Coatings for Cardiovascular Implants

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator: Paul T. Hamilton
Award Amount: $297,258.00
Abstract:
DESCRIPTION (provided by applicant): Summary Improving cardiovascular implants to reduce thrombosis and other confounds has been a long-term goal of medical science. Grafts and endovascular stents have been recently modified to include new materials, atta ched cells or drug-eluting polymers to make… More

Bioactive Peptide Coatings for Synthetic Bone Grafts in Dental Applications

Award Year / Program / Phase: 2008 / SBIR / Phase II
Agency: HHS
Principal Investigator: Hanne Gron
Award Amount: $1,564,613.00
Abstract:
DESCRIPTION (provided by applicant): According to the National Institute of Dental and Craniofacial Research, 86% of adults over 70 years of age have at least moderate periodontitis with over a quarter having lost their teeth, resulting in serious health a nd quality of life repercussions. Bone… More

Point of Care Attachment of Antibiotics onto Metal Implants

Award Year / Program / Phase: 2008 / SBIR / Phase II
Agency: HHS
Principal Investigator: Paul T. Hamilton
Award Amount: $1,831,205.00
Abstract:
DESCRIPTION (provided by applicant): Infection surrounding metal implants is a common and sometimes devastating cause of implant failure in a number of fields including oral, craniomaxillofacial (CMF), orthopedic, and cardiovascular surgery. These infectio ns, which arise from the establishment of… More

Peptide conjugation for Co-Delivery of Growth Factors and Stem Cells

Award Year / Program / Phase: 2008 / SBIR / Phase II
Agency: HHS
Principal Investigator:
Award Amount: $2,205,548.00
Abstract:
DESCRIPTION (provided by applicant): Growth factors are potent signaling molecules, initiating essential cellular programs for differentiation, proliferation and survival. Only recently have large molecules like growth factors, been employed to enhance the efficacy and specificity of medical… More

Subgingival Drug Delivery for Periodontitis Prevention and Treatment

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Martyn Darby
Award Amount: $293,590.00
Abstract:
DESCRIPTION (provided by applicant): In addition to the role oral infections play in promoting tooth loss, periodontitis has also been associated with increasing the risk of other medical conditions such as coronary artery disease, stroke and myocardial i nfarction. Approximately 50% of the US… More

Novel Formulations for Injectable Growth Factors

Award Year / Program / Phase: 2009 / SBIR / Phase II
Agency: HHS
Principal Investigator: Bruce Lamb
Award Amount: $1,679,377.00
Abstract:
DESCRIPTION (provided by applicant): Over 6.3 million fractures occur each year in the United States alone (Praemer et al. 1999) and approximately 15% of fractures exhibit delayed or impaired healing. The clinical applications currently used to treat dela yed fracture require open surgery to insert… More

Growth Factor Coated Sutures for Improved Tendon Repair

Award Year / Program / Phase: 2009 / SBIR / Phase II
Agency: HHS
Principal Investigator: Paul T. Hamilton
Award Amount: $1,568,731.00
Abstract:
DESCRIPTION (provided by applicant): Of the nearly 5 million patients who visit a physician for tendon pain each year in the US, approximately 200,000 go on to have a surgical repair. And while surgical repair has a high-rate of symptom relief, recovering patients are routinely immobilized for… More

Self Assembling High Affinity Peptides for Point of Care Drug-Device Combinations

Award Year / Program / Phase: 2009 / SBIR / Phase II
Agency: HHS
Principal Investigator: Shrikumar A. Nair
Award Amount: $1,942,658.00
Abstract:
DESCRIPTION (provided by applicant): Infection surrounding metal implants is a common and sometimes devastating cause of implant failure in a number of fields including oral, craniomaxillofacial (CMF), orthopedic, and cardiovascular surgery. These infectio ns, which arise from the establishment of… More

Peptide-mediated Attachment of Drug-loaded Microparticles to Medical Devices

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Jonathan A. Hodges
Award Amount: $309,411.00
Abstract:
DESCRIPTION (provided by applicant): Mediastinitis is a common and sometimes devastating complication following open heart surgery. Despite the use of prophylactic systemic antibiotics and improved surgical techniques, bacterial infection remains a serious complication following almost all surgical… More

Topical negative pressure dressings for the prevention of chronic wound biofilm

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Guy Orgambide
Award Amount: $316,996.00
Abstract:
DESCRIPTION (provided by applicant): Chronic wounds are a significant public-health problem, imposing a high cost on society and presenting patients with significant quality of life limitations. A large proportion of patients with chronic wounds, such as d iabetic foot ulcers, and venous leg ulcers,… More

Antibiotic-binding peptides for biofilm prevention on ventriculoperitoneal shunts

Award Year / Program / Phase: 2009 / SBIR / Phase II
Agency: HHS
Principal Investigator: Hanne Gron
Award Amount: $1,599,399.00
Abstract:
DESCRIPTION (provided by applicant): Ventriculoperitoneal (VP) shunts are used to treat pediatric and neonatal hydrocephalus in severe cases, representing approximately 1/3rd of affected infants. Due to the high susceptibility for infection and mechanical breakdown, the failure rate of VP shunts is… More

Bone Targeting Peptides for the Prevention and Treatment of Infection

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Hanne Gron
Award Amount: $303,851.00
Abstract:
DESCRIPTION (provided by applicant): Summary Targeted drug delivery has been a long-term goal for biomedical science. Of specific interest, are those drugs which exert powerful therapeutic effects but cannot be prominently used due to harmful side- effects during systemic delivery? Bone has become… More

Localized Growth Factor Therapy for Surgical Hernia Repair

Award Year / Program / Phase: 2010 / SBIR / Phase II
Agency: HHS
Principal Investigator: Bruce Lamb
Award Amount: $1,811,074.00
Abstract:
DESCRIPTION (provided by applicant): Over 700,000 surgical hernia repairs are performed each year in the United States and despite recent advances, a significant rate of recurrence persists. The incorporation of biocompatible mesh to strengthen the abdomin al fascia has largely replaced high-tension… More

Development of an adipose-derived stem cell isolation matrix

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Martyn Darby
Award Amount: $308,237.00
Abstract:
DESCRIPTION (provided by applicant): Mesenchymal stem cells (MSCs) are an adult stem cell population, typically isolated from bone marrow aspirates, and are capable of self-renewal, expansion in culture, and differentiation into adipocytes, chondrocytes, a nd osteoblasts. These cells are being… More

Recombinant expression of a biomaterial-targeting BMP-2 containing a peptide tag

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Hanne Gron
Award Amount: $312,224.00
Abstract:
DESCRIPTION (provided by applicant): The emergence of biological therapeutics, including cells, peptides, and proteins, has allowed medical science to address a number of unmet clinical needs. Often these agents are extremely potent, specifically activatin g endogenous signaling cascades to promote… More

Bone cements for delivery of osteoinductive growth factors

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Jonathan A. Hodges – 608-265-5640
Award Amount: $318,402.00
Abstract:
DESCRIPTION (provided by applicant): Bone cements are widely used in maxillofacial surgery, repair of cranial defects, and dental fillings. Calcium phosphate bone cements are useful in many types of bone repair because they conform to the defect area, harden in situ, and can be resorbed and replaced… More

Delivery of Adipose Derived Stem Cells for Healing Surgical Hernia Repairs

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Bruce Lamb – 919-433-2228
Award Amount: $327,042.00
Abstract:
DESCRIPTION (provided by applicant): Over 700,000 surgical hernia repairs are performed each year in the United States and despite recent advances, a significant rate of recurrence persists. Incisional or visceral hernia repairs account for 100,000 of these surgeries costing 1.7B annually, and have… More

Point of Care Adult Stem Cell Isolation

Award Year / Program / Phase: 2011 / SBIR / Phase II
Agency: HHS
Principal Investigator: Hanne Gron – 919-597-6222
Award Amount: $1,863,609.00
Abstract:
DESCRIPTION (provided by applicant): Approximately 500,000 bone-grafting procedures are performed each year in the United States.5 Autologous iliac crest bone graft continues to be the gold standard, because it provides essential elements for bone formation: progenitor cells, an osteoconductive… More

Peptide conjugation for Co-Delivery of Growth Factors and Stem Cells

Award Year / Program / Phase: 2012 / SBIR / Phase II
Agency: HHS
Principal Investigator: Shrikumar A. Nair – 919-433-2268
Award Amount: $1,479,035.00
Abstract:
DESCRIPTION (provided by applicant): Autologous stem cells and growth factors provide valuable therapies for a variety of indications. When stem cells and growth factors are co-delivered, they produce a greater therapeutic effect than delivery of either stem cells or growth factors alone. However,… More

Development of an adipose-derived stem cell isolation matrix

Award Year / Program / Phase: 2012 / SBIR / Phase II
Agency: HHS
Principal Investigator: Martyn Darby – 215-955-4504
Award Amount: $2,383,956.00
Abstract:
DESCRIPTION (provided by applicant): Approximately 500,000 bone-grafting procedures are performed each year in the United States. Autologous iliac crest bone graft continues to be the gold standard, because it provides essential elements for bone formation: progenitor cells, an osteoconductive… More

Bioactive Peptide Coatings for Synthetic Bone Grafts

Award Year / Program / Phase: 2012 / SBIR / Phase II
Agency: HHS
Principal Investigator: Jonathan A. Hodges – 608-265-5640
Award Amount: $1,676,998.00
Abstract:
DESCRIPTION (provided by applicant): Back pain is one of the leading reasons for physician visits in the United States and in many cases requires surgical intervention. In the United States, there are over 500,000 spinal fusion surgeries every year, and the frequency of these surgeries is projected… More

Delivery of Adipose Derived Stem Cells for Healing Surgical Hernia Repairs

Award Year / Program / Phase: 2012 / SBIR / Phase II
Agency: HHS
Principal Investigator: Bruce Lamb – 919-433-2228
Award Amount: $1,823,125.00
Abstract:
DESCRIPTION (provided by applicant): Over 700,000 surgical hernia repairs are performed each year in the United States and despite recent advances, a significant rate of recurrence persists. Of these surgeries, 100,000 are for incisional or visceral herniarepairs, which cost 1.7B annually and have a… More

Novel coatings on titanium implants for the delivery of stem cells

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Martyn Darby – 215-955-4504
Award Amount: $149,771.00
Abstract:
DESCRIPTION (provided by applicant): Calvarial reconstruction continues to present challenges for surgeons. Although the gold standard for restoration of the skull is autologous bone, particularly from the removed flap, substitutes are often necessary dueto the flap becoming infected or infiltrated… More

Peptide-coated skin substitutes for the treatment of burn injuries and wounds

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Bruce Lamb – 919-433-2228
Award Amount: $306,524.00
Abstract:
DESCRIPTION (provided by applicant): Burn injuries and chronic wounds present a significant burden to patients and the US healthcare system. Each year in the US, there are 450,000 burns that require medical treatment and 45,000 burns that require hospitalization. One of the most common causes of… More